Journals / İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi / 2017 / Cilt: 7 - Sayı: 2

Kawasaki disease: An evaluation of pediatric patients in Erzurum

Kawasaki hastalığı: Erzurum ilinde izlenen çocuk hastaların değerlendirilmesi

Pages
113–120
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It is important to raise awareness of KD, as rapid treatment can prevent complications.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Kawasaki disease (KD) is a frequently seen acquired childhood heart disease.
📊
Key Findings & Data:Results: Patients' mean age was 4.1±2.4 years; eight (66.6%) patients were male and four (33.3%) female.
💡
Conclusion & Impact:Conclusion: It is important to raise awareness of KD, as rapid treatment can prevent complications.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Kawasaki disease (KD) is a frequently seen acquired childhood heart disease. This multisystemic vasculitic syndrome involves most organs and systems. The incidence in Turkey is unknown. Methods: Patients with KD at the Erzurum Regional Training and Research Hospital were retrospectively evaluated. Results: Patients' mean age was 4.1±2.4 years; eight (66.6%) patients were male and four (33.3%) female. Symptoms persisted for a mean 8.5±3.5 days. Ten (83.3%) patients were diagnosed with acute KD and two (16.6%) with subacute KD. Admission was most common in the 4th and 9th months with three cases each. All patients had fever for at least five days and oral mucosa changes. Other findings were conjunctivitis and polymorphic exanthems in 11 (91.7%) patients. Ten (83.3%) patients had complete KD and two 2 (16.6%) incomplete KD. Two (16.6%) patients had gallbladder hydrops and two (16.6%) had BCG vaccine reactivation. White blood cell count, CRP, and ESR were above normal limits. Thrombocytosis was present in four (33.3%), hyponatremia in eight (66.6%), hypoalbuminemia in three (25%), and sterile pyuria in three (25%) patients. Four (33.3%) patients had abnormal echocardiography findings (two patients had left coronary artery dilation, and two minimal mitral insufficiency and decrement in left ventricular functions that were reversed with IVIG treatment). All patients received IVIG; nine received high-dose and three low-dose acetylsalicylic acid. One (8.3%) patient received a secondary dose of IVIG. Coronary findings persisted, although these regressed on check-ups on the 3rd and 6th months, and acetylsalicylylic acid treatment was continued. Conclusion: It is important to raise awareness of KD, as rapid treatment can prevent complications.

Özet

Amaç: Kawasaki hastalığı (KH) çocukluk çağında edinilmiş kalp hastalıklarının en sık nedenlerindendir. Ülkemizdeki insidansı bilinmeyen hastalık multisistemik vaskülitik bir sendrom olup, pek çok organı ve sistemi etkilemektedir. Yöntem: Erzurum Bölge Eğitim ve Araştırma Hastanesinde KH tanısı konulan hastaların klinik ve laboratuvar bulguları retrospektif olarak incelendi.Bulgular: Hastaların yaş ortalaması 4,1±2,4 yıldı, 8'i (%66,6) erkek, 4'ü (%33,3) kızdı. Hastaların başvuruda ortalamaları 8,5±3,5 gündü, semptomları mevcuttu. On (%83,3) hastaya akut, 2 (%16,6) hastaya subakut KH (12 ve 17 gün) tanısı konuldu. Hastaneye en sık başvuru üçer olguyla 4. ve 9. aylarda oldu. Tüm hastaların en az 5 günden beri süren ateşi ve oral mukoza değişiklikleri mevcuttu. Diğer sık bulgular, on birer (%91,7) hastada konjunktivit ve polimorfik ekzantemdi. On (%83,3) hastanın komplet, 2 (%16,6) hastanın inkomplet KH vardı. İkişer (%16,6) hastada safra kesesi hidropsu ve BCG aşısı reaktivasyonu saptandı. Çalışmada, beyaz küre sayısı, C-reaktif protein ve eritrosit sedimentasyon hızı ortalama değerleri normal sınırların üzerindeydi. Trombositoz 4 (%33,3), hiponatremi 8 (%66,6), hipoalbüminemi 3 (%25) ve steril piyüri 3 (%25) hastada gözlendi. Dört (%33,3) hastada ekokardiyografide bulgu (2'sinde sol koroner arterde dilatasyon, 2'sindeyse intravenöz immünglobulin [IVIG] tedavisiyle gerilemiş olan hafif mitral yetmezlik ve sol ventrikül fonksiyonlarında azalma) saptandı. Tüm hastalara tanı anında IVIG, hastaların 9'una yüksek doz, 3'üne düşük doz asetil salisilat başlandı. Bir (%8,3) hastaya ikinci doz IVIG verildi. Koroner dilatasyonu bulgularının 3. ve 6. aydaki kontrollerde gerilese de devam ettiği görülerek asetil salisilat tedavilerine devam edildi. Sonuç: Nadir görülen ancak yüksek morbidite riskine sahip KH ülkemizde Doğu Anadolu bölgesinde de görülmektedir. Hızlı tedaviyle komplikasyonlar önlenebileceği için hastalığın hakkında farkındalığın artması önemlidir.

🔖

Cite This Article

KARA, S. S., GÜLLÜ, U. U., BALABAN, İ. (2017). Kawasaki disease: An evaluation of pediatric patients in Erzurum. İzmir Dr. Behçet Uz Çocuk Hastanesi Dergisi, Cilt: 7 - Sayı: 2, 113–120. https://ajindex.com/articles/198455

📄 Full Text PDF Viewer

↗New Tab

References (1)

  1. 1. Makino N, Nakamura Y, Yashiro M, Ae R, Tsuboi S, Aoyama Y, et al. Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. J Epidemiol 2015;25:239-245. https://doi.org/10.2188/jea.JE20140089 2. Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-1385. https://doi.org/10.1161/01.CIR.94.6.1379 3. Terai M, Shulman ST. Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose. J Pediatr 1997;131:888-893. https://doi.org/10.1016/S0022-3476(97)70038-6 4. Shulman ST. Kawasaki Disease. In Cherry J, HarrisonDemmler GJ, Kaplan SL, Steinbach WJ, Hotez P (eds). Feigin and Cherry's Textbook of Pediatric Infectious Diseases. 7th Edition. Philadelphia, PA. Elsevier Saunders; 2014. p. 1064-1085. 5. Barone SR, Pontrelli LR, Krilov LR. The differentiation of classic Kawasaki disease, atypical Kawasaki disease, and acute adenoviral infection: use of clinical features and a rapid direct fluorescent antigen test. Arch Pediatr Adolesc Med 2000;154:453-456. https://doi.org/10.1001/archpedi.154.5.453 6. Kumar S, Vaidyanathan B, Gayathri S, Rajam L. Systemic onset juvenile idiopathic arthritis with macrophage activation syndrome misdiagnosed as Kawasaki disease: case report and literature review. Rheumatol Int 2013;33:1065-1069. https://doi.org/10.1007/s00296-010-1650-8 7. Burns JC, Mason WH, Glode MP, Shulman ST, Melish ME, Meissner C, et al. Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group. J Pediatr 1991;118:680-686. https://doi.org/10.1016/S0022-3476(05)80026-5 8. Garrido-García LM, López-Amézquita M, Villaverde-Rosas R. Kawasaki disease in a healthcare provider: an adult case in a paediatric resident. Cardiol Young 2016;26:976-978. https://doi.org/10.1017/S1047951115002644 9. Yeom JS, Woo HO, Park JS, Park ES, Seo JH, Youn HS. Kawasaki disease in infants. Korean J Pediatr 2013;56:377- 382. https://doi.org/10.3345/kjp.2013.56.9.377 10. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council o